المؤلفون: Morschhauser, F, Dahiya, S, Palomba, ML, Garcia-Sancho, AM, Ortega, JLR, Kuruvilla, J, Jager, U, Cartron, G, Izutsu, K, Dreyling, M, Kahl, B, Ghesquieres, H, Ardeshna, K, Goto, H, Barbui, AM, Abramson, JS, Borchmann, P, Fleury, I, Mielke, S, Skarbnik, A, de Vos, S, Kamdar, M, Karmali, R, Viardot, A, Farazi, T, Fasan, O, Lymp, J, Vedal, M, Nishii, R, Avilion, A, Papuga, J, Kumar, J, Nastoupil, LJ

المصدر: Nature medicine.

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:158364474Test

المؤلفون: Kuruvilla J., Armand P., Hamadani M., Kline J., Moskowitz C. H., Avigan D., Brody J. D., Ribrag V., Herrera A. F., Morschhauser F., Kanate A., Zinzani P. L., Bitran J., Ghesquieres H., Schuster S. J., Farooqui M., Marinello P., Bartlett N. L.

المساهمون: Kuruvilla J., Armand P., Hamadani M., Kline J., Moskowitz C.H., Avigan D., Brody J.D., Ribrag V., Herrera A.F., Morschhauser F., Kanate A., Zinzani P.L., Bitran J., Ghesquieres H., Schuster S.J., Farooqui M., Marinello P., Bartlett N.L.

مصطلحات موضوعية: B-cell lymphoma, Non-Hodgkin lymphoma, PD-L1, pembrolizumab

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36398795; info:eu-repo/semantics/altIdentifier/wos/WOS:000889500100001; volume:64; issue:1; firstpage:130; lastpage:139; numberofpages:10; journal:LEUKEMIA & LYMPHOMA; https://hdl.handle.net/11585/960713Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85142278083

الإتاحة: https://doi.org/10.1080/10428194.2022.2136956Test
https://hdl.handle.net/11585/960713Test

المؤلفون: Ansell S. M., Brockelmann P. J., von Keudell G., Lee H. J., Santoro A., Zinzani P. L., Collins G. P., Cohen J. B., de Boer J. P., Kuruvilla J., Savage K. J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M. A., Engert A., Armand P.

المساهمون: Ansell S.M., Brockelmann P.J., von Keudell G., Lee H.J., Santoro A., Zinzani P.L., Collins G.P., Cohen J.B., de Boer J.P., Kuruvilla J., Savage K.J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M.A., Engert A., Armand P.

مصطلحات موضوعية: Nivolumab, relapsed/refractory, Hodgkin lymphoma, 5-year survival, CheckMate 205 study

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37530622; info:eu-repo/semantics/altIdentifier/wos/WOS:001097076600001; volume:7; issue:20; firstpage:6266; lastpage:6274; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/960011Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85175416545; https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classicalTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2023010334Test
https://hdl.handle.net/11585/960011Test
https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classicalTest

المؤلفون: Zinzani P. L., Santoro A., Gritti G., Brice P., Barr P. M., Kuruvilla J., Cunningham D., Kline J., Johnson N. A., Mehta-Shah N., Lisano J., Wen R., Akyol A., Moskowitz A. J.

المساهمون: Zinzani P.L., Santoro A., Gritti G., Brice P., Barr P.M., Kuruvilla J., Cunningham D., Kline J., Johnson N.A., Mehta-Shah N., Lisano J., Wen R., Akyol A., Moskowitz A.J.

مصطلحات موضوعية: Nivolumab, brentuximab vedotin, R/R primary mediastinal large B-cell lymphoma

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001080509800001; volume:7; issue:18; firstpage:5272; lastpage:5280; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/960064Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85173482930; https://ashpublications.org/bloodadvances/article/7/18/5272/496496/Nivolumab-combined-with-brentuximab-vedotin-for-RTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2023010254Test
https://hdl.handle.net/11585/960064Test
https://ashpublications.org/bloodadvances/article/7/18/5272/496496/Nivolumab-combined-with-brentuximab-vedotin-for-RTest

المؤلفون: Kuruvilla, J., Armand, P., Hamadani, M., Kline, J., Moskowitz, C. H., Avigan, D., Brody, J. D., Ribrag, V., Herrera, A. F., Morschhauser, Franck, Kanate, A., Zinzani, P. L., Bitran, J., Ghesquieres, H., Schuster, S. J., Farooqui, M., Marinello, P., Bartlett, N. L.

المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

مصطلحات موضوعية: Non-Hodgkin lymphoma, pembrolizumab, B-cell lymphoma, PD-L1

وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

العلاقة: Leukemia & lymphoma; Leuk Lymphoma; http://hdl.handle.net/20.500.12210/82385Test

الإتاحة: https://doi.org/20.500.12210/82385Test
https://hdl.handle.net/20.500.12210/82385Test

المؤلفون: Zinzani P. L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N. A., de Oliveira J. S. R., Buccheri V., Perini G. F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T. L., Nahar A., Kuruvilla J.

المساهمون: Zinzani P.L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N.A., de Oliveira J.S.R., Buccheri V., Perini G.F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T.L., Nahar A., Kuruvilla J.

مصطلحات موضوعية: Quality-of-life, pembrolizumab, brentuximab vedotin, relapsed/refractory, Hodgkin lymphoma

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34644372; info:eu-repo/semantics/altIdentifier/wos/WOS:000754639300004; volume:6; issue:2; firstpage:590; lastpage:599; numberofpages:10; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/904791Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123548552; https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vsTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004970Test
https://hdl.handle.net/11585/904791Test
https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vsTest

المؤلفون: Kuruvilla, J., Armand, P., Hamadani, M., Kline, J., Moskowitz, C. H., Avigan, D., Brody, J. D., Ribrag, V., Herrera, A. F., Morschhauser, Franck, Kanate, A., Zinzani, P. L., Bitran, J., Ghesquieres, H., Schuster, S. J., Farooqui, M., Marinello, P., Bartlett, N. L.

المساهمون: Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

المصدر: ISSN: 1042-8194.

مصطلحات موضوعية: Non-Hodgkin lymphoma, pembrolizumab, B-cell lymphoma, PD-L1, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36398795; hal-04144480; https://hal.univ-lille.fr/hal-04144480Test; https://hal.univ-lille.fr/hal-04144480/documentTest; https://hal.univ-lille.fr/hal-04144480/file/Pembrolizumab%20for%20patients%20with%20non%20Hodgkin%20lymphoma%20phase%201b%20KEYNOTE%20013%20study.pdfTest; PUBMED: 36398795

الإتاحة: https://doi.org/10.1080/10428194.2022.2136956Test
https://hal.univ-lille.fr/hal-04144480Test
https://hal.univ-lille.fr/hal-04144480/documentTest
https://hal.univ-lille.fr/hal-04144480/file/Pembrolizumab%20for%20patients%20with%20non%20Hodgkin%20lymphoma%20phase%201b%20KEYNOTE%20013%20study.pdfTest

المؤلفون: Zinzani, PL, Ramchandren, R, Santoro, A, Paszkiewicz-Kozik, E, Gasiorowski, R, Johnson, NA, de Oliveira, JSR, Buccheri, V, Perini, GF, Dickinson, M, McDonald, A, Ozcan, M, Sekiguchi, N, Zhu, Y, Raut, M, Saretsky, TL, Nahar, A, Kuruvilla, J

العلاقة: pii: 477276; Zinzani, P. L., Ramchandren, R., Santoro, A., Paszkiewicz-Kozik, E., Gasiorowski, R., Johnson, N. A., de Oliveira, J. S. R., Buccheri, V., Perini, G. F., Dickinson, M., McDonald, A., Ozcan, M., Sekiguchi, N., Zhu, Y., Raut, M., Saretsky, T. L., Nahar, A. & Kuruvilla, J. (2022). Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. BLOOD ADVANCES, 6 (2), pp.590-599. https://doi.org/10.1182/bloodadvances.2021004970Test.; http://hdl.handle.net/11343/301626Test

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004970Test
http://hdl.handle.net/11343/301626Test

المؤلفون: Salles, G, Schuster, SJ, Dreyling, M, Fischer, L, Kuruvilla, J, Patten, PEM, von Tresckow, B, Smith, SM, Jimenez-Ubieto, A, Davis, KL, Anjos, C, Chu, J, Zhang, J, Bodoni, CL, Thieblemont, C, Fowler, NH, Dickinson, M, Martinez-Lopez, J, Wang, Y, Link, BK

العلاقة: pii: 486254; Salles, G., Schuster, S. J., Dreyling, M., Fischer, L., Kuruvilla, J., Patten, P. E. M., von Tresckow, B., Smith, S. M., Jimenez-Ubieto, A., Davis, K. L., Anjos, C., Chu, J., Zhang, J., Bodoni, C. L., Thieblemont, C., Fowler, N. H., Dickinson, M., Martinez-Lopez, J., Wang, Y. & Link, B. K. (2022). Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. BLOOD ADVANCES, 6 (22), pp.5835-5843. https://doi.org/10.1182/bloodadvances.2022008150Test.; http://hdl.handle.net/11343/335833Test

الإتاحة: https://doi.org/10.1182/bloodadvances.2022008150Test
http://hdl.handle.net/11343/335833Test

المؤلفون: Kuruvilla, J., Armand, P., Herrera, A. F., Ribrag, V., Brice, P., Thieblemont, C., Von Tresckow, B., Kim, E., Marinello, P., Chakraborty, S., Orlowski, R., Zinzani, P. L.

المصدر: HemaSphere ; volume 6, page 1236-1237 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000848268.24972.7cTest